Tag: Vivek Vishwanathan
Trilegal acts for JB Pharmaceuticals on Novartis acquisition
Trilegal advised JB Pharmaceuticals in its acquisition of a portfolio of specific ophthalmology brands from Novartis for INR10.9 billion
Trilegal advised JB Pharmaceuticals in its acquisition of a portfolio of specific ophthalmology brands from Novartis for INR10.9 billion
Following months of market research, we have selected these outstanding in-house counsel and their teams